A previous study has demonstrated that VEGF-A and VEGFR contribute to the development in AAA through inhibition of mural angiogenesis, MMP production, myeloid cell chemotaxis, and circulating monocytes30. This evidence concerns the gene KDR and triple-A syndrome.